QINLOCK 50 mg/1
Ripretinib · TABLET · Deciphera Pharmaceuticals, LLC
No Recall History
Plain English
QINLOCK is a tablet containing ripretinib at 50 mg/1, taken oral. Manufactured by Deciphera Pharmaceuticals, LLC.
Key Facts
- Brand Name
- QINLOCK
- Generic Name
- Ripretinib
- NDC Code (Product)
73207-101- Manufacturer
- Deciphera Pharmaceuticals, LLC
- Strength
- 50 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA213973
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 05/15/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is QINLOCK used for?
QINLOCK contains Ripretinib. It is a tablet taken oral. Consult your doctor for specific uses.
Is QINLOCK a controlled substance?
QINLOCK is not classified as a controlled substance by the DEA.
What is the generic name for QINLOCK?
The generic name for QINLOCK is Ripretinib. There are no other listed brand versions of Ripretinib.
What is the NDC code for QINLOCK 50 mg/1?
The NDC (National Drug Code) for QINLOCK 50 mg/1 is 73207-101, listed by Deciphera Pharmaceuticals, LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)